The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Unger, W. W. J.
Right arrow Articles by Samsom, J. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Unger, W. W. J.
Right arrow Articles by Samsom, J. N.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 2003, 171: 4592-4603.
Copyright © 2003 by The American Association of Immunologists

Early Events in Peripheral Regulatory T Cell Induction via the Nasal Mucosa

Wendy W. J. Unger1,*, Femke Hauet-Broere*,{dagger}, Wendy Jansen*, Lisette A. van Berkel*, Georg Kraal* and Janneke N. Samsom2,*

* Department of Molecular Cell Biology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands; and {dagger} Department of Condition and Disease Specific Research, Numico Research, Wageningen, The Netherlands

Nasal application of soluble Ags leads to Ag-specific suppression of systemic immune responses. This tolerance can be transferred to naive mice by CD4+ regulatory T cells (TR cells) from the spleen, but little is known about the induction of mucosal TR cells in vivo. To investigate the induction of TR cells in the nose-draining cervical lymph node (CLN), CD4+ T cells from DO11.10 OVA TCR transgenic mice were transferred to BALB/c recipients. Within 48 h after nasal OVA application, CD4+ DO11.10 T cells in CLN, but not in the peripheral lymph node, had divided. Similarly, nonmucosal (i.m.) OVA application also induced CD4+ DO11.10 T cells to proliferate in the draining inguinal lymph node (ILN), yet more vigorously and with different kinetics than the CD4+ DO11.10 T cells in CLN. Functional analysis revealed that only proliferating CD4+ DO11.10 T cells from CLN, and not ILN, could transfer tolerance to naive recipients. CD4+ DO11.10 T cells from CLN were phenotypically similar to CD4+ DO11.10 T cells from ILN, however, in CLN a higher percentage of CD25+ proliferating CD4+ DO11.10 T cells were detected compared with ILN. CD25 is not a discriminative marker for mucosal TR cells because both CD25+ and CD25- CD4+ DO11.10 T cells from the CLN could suppress delayed type hypersensitivity responses in adoptive transfer. These findings demonstrate that although striking similarities exist between the differentiation of TR and effector T cells, this does not include their function. We are the first to demonstrate that functional TR cells, which reside within both CD25+ and CD25- subsets, can be isolated from CLN as early as 3 days after nasal OVA application.




This article has been cited by other articles:


Home page
J. Immunol.Home page
F. Broere, L. Wieten, E. I. Klein Koerkamp, J. A. G. van Roon, T. Guichelaar, F. P. J. G. Lafeber, and W. van Eden
Oral or Nasal Antigen Induces Regulatory T Cells That Suppress Arthritis and Proliferation of Arthritogenic T Cells in Joint Draining Lymph Nodes
J. Immunol., July 15, 2008; 181(2): 899 - 906.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Rynda, M. Maddaloni, D. Mierzejewska, J. Ochoa-Reparaz, T. Maslanka, K. Crist, C. Riccardi, B. Barszczewska, K. Fujihashi, J. R. McGhee, et al.
Low-Dose Tolerance Is Mediated by the Microfold Cell Ligand, Reovirus Protein {sigma}1
J. Immunol., April 15, 2008; 180(8): 5187 - 5200.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Siewert, U. Lauer, S. Cording, T. Bopp, E. Schmitt, A. Hamann, and J. Huehn
Experience-Driven Development: Effector/Memory-Like {alpha}E+Foxp3+ Regulatory T Cells Originate from Both Naive T Cells and Naturally Occurring Naive-Like Regulatory T Cells
J. Immunol., January 1, 2008; 180(1): 146 - 155.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. N. Samsom, A. P. J. van der Marel, L. A. van Berkel, J. M. L. M. van Helvoort, Y. Simons-Oosterhuis, W. Jansen, M. Greuter, R. L. H. Nelissen, C. M. L. Meeuwisse, E. E. S. Nieuwenhuis, et al.
Secretory Leukoprotease Inhibitor in Mucosal Lymph Node Dendritic Cells Regulates the Threshold for Mucosal Tolerance
J. Immunol., November 15, 2007; 179(10): 6588 - 6595.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. P. J. van der Marel, J. N. Samsom, M. Greuter, L. A. van Berkel, T. O'Toole, G. Kraal, and R. E. Mebius
Blockade of IDO Inhibits Nasal Tolerance Induction
J. Immunol., July 15, 2007; 179(2): 894 - 900.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. E. Wikstrom, E. Batanero, M. Smith, J. A. Thomas, C. von Garnier, P. G. Holt, and P. A. Stumbles
Influence of Mucosal Adjuvants on Antigen Passage and CD4+ T Cell Activation during the Primary Response to Airborne Allergen
J. Immunol., July 15, 2006; 177(2): 913 - 924.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
H. Keino, M. Takeuchi, T. Kezuka, T. Hattori, M. Usui, O. Taguchi, J. W. Streilein, and J. Stein-Streilein
Induction of Eye-Derived Tolerance Does Not Depend on Naturally Occurring CD4+CD25+ T Regulatory Cells.
Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 1047 - 1055.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Alvarez, F. K. Swirski, T.-C. Yang, R. Fattouh, K. Croitoru, J. L. Bramson, M. R. Stampfli, and M. Jordana
Inhalation Tolerance Is Induced Selectively in Thoracic Lymph Nodes but Executed Pervasively at Distant Mucosal and Nonmucosal Tissues
J. Immunol., February 15, 2006; 176(4): 2568 - 2580.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
C. Porporatto, I. D. Bianco, and S. G. Correa
Local and systemic activity of the polysaccharide chitosan at lymphoid tissues after oral administration
J. Leukoc. Biol., July 1, 2005; 78(1): 62 - 69.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
Y. Chung, S.-H. Lee, D.-H. Kim, and C.-Y. Kang
Complementary role of CD4+CD25+ regulatory T cells and TGF-{beta} in oral tolerance
J. Leukoc. Biol., June 1, 2005; 77(6): 906 - 913.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. N. Samsom, L. A. van Berkel, J. M. L. M. van Helvoort, W. W. J. Unger, W. Jansen, T. Thepen, R. E. Mebius, S. S. Verbeek, and G. Kraal
Fc{gamma}RIIB Regulates Nasal and Oral Tolerance: A Role for Dendritic Cells
J. Immunol., May 1, 2005; 174(9): 5279 - 5287.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. M. Eriksson, K. M. Schon, and N. Y. Lycke
The Cholera Toxin-Derived CTA1-DD Vaccine Adjuvant Administered Intranasally Does Not Cause Inflammation or Accumulate in the Nervous Tissues
J. Immunol., September 1, 2004; 173(5): 3310 - 3319.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J.-G. Chai, E. James, H. Dewchand, E. Simpson, and D. Scott
Transplantation tolerance induced by intranasal administration of HY peptides
Blood, May 15, 2004; 103(10): 3951 - 3959.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.